nodes	percent_of_prediction	percent_of_DWPC	metapath
Adapalene—RXRG—a6b1 and a6b4 Integrin signaling—MST1R—bone cancer	0.0494	0.0709	CbGpPWpGaD
Adapalene—RXRB—a6b1 and a6b4 Integrin signaling—MST1R—bone cancer	0.0464	0.0666	CbGpPWpGaD
Adapalene—RXRA—a6b1 and a6b4 Integrin signaling—MST1R—bone cancer	0.0242	0.0347	CbGpPWpGaD
Adapalene—RARG—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.0229	0.0328	CbGpPWpGaD
Adapalene—RARG—Nuclear Receptors—NR1I2—bone cancer	0.0209	0.03	CbGpPWpGaD
Adapalene—RARB—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.0205	0.0294	CbGpPWpGaD
Adapalene—Herpes labialis—Epirubicin—bone cancer	0.0197	0.0649	CcSEcCtD
Adapalene—RARA—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.0197	0.0282	CbGpPWpGaD
Adapalene—RXRG—Nuclear Receptors—NR1I2—bone cancer	0.0191	0.0275	CbGpPWpGaD
Adapalene—RARB—Nuclear Receptors—NR1I2—bone cancer	0.0188	0.0269	CbGpPWpGaD
Adapalene—Herpes labialis—Doxorubicin—bone cancer	0.0182	0.06	CcSEcCtD
Adapalene—RARA—Nuclear Receptors—NR1I2—bone cancer	0.018	0.0258	CbGpPWpGaD
Adapalene—RXRB—Nuclear Receptors—NR1I2—bone cancer	0.018	0.0258	CbGpPWpGaD
Adapalene—Papilloedema—Cisplatin—bone cancer	0.0175	0.0576	CcSEcCtD
Adapalene—RARG—Nuclear Receptor transcription pathway—NR1I2—bone cancer	0.0165	0.0237	CbGpPWpGaD
Adapalene—RXRA—Liver X Receptor Pathway—CYP3A4—bone cancer	0.0159	0.0229	CbGpPWpGaD
Adapalene—RXRG—Nuclear Receptor transcription pathway—NR1I2—bone cancer	0.0151	0.0217	CbGpPWpGaD
Adapalene—RARB—Nuclear Receptor transcription pathway—NR1I2—bone cancer	0.0148	0.0213	CbGpPWpGaD
Adapalene—RXRB—Nuclear Receptor transcription pathway—NR1I2—bone cancer	0.0142	0.0204	CbGpPWpGaD
Adapalene—RARA—Nuclear Receptor transcription pathway—NR1I2—bone cancer	0.0142	0.0204	CbGpPWpGaD
Adapalene—RARG—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.0134	0.0192	CbGpPWpGaD
Adapalene—Oral herpes—Epirubicin—bone cancer	0.0121	0.0399	CcSEcCtD
Adapalene—RARB—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.012	0.0172	CbGpPWpGaD
Adapalene—RARA—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.0115	0.0165	CbGpPWpGaD
Adapalene—Oral herpes—Doxorubicin—bone cancer	0.0112	0.0369	CcSEcCtD
Adapalene—Sunburn—Methotrexate—bone cancer	0.0101	0.0333	CcSEcCtD
Adapalene—RXRA—Farnesoid X Receptor  Pathway—CYP3A4—bone cancer	0.00953	0.0137	CbGpPWpGaD
Adapalene—RXRA—Nuclear Receptors—NR1I2—bone cancer	0.00937	0.0135	CbGpPWpGaD
Adapalene—Optic neuritis—Cisplatin—bone cancer	0.00904	0.0298	CcSEcCtD
Adapalene—RARG—Generic Transcription Pathway—ZNF77—bone cancer	0.00843	0.0121	CbGpPWpGaD
Adapalene—RXRG—Generic Transcription Pathway—ZNF77—bone cancer	0.00771	0.0111	CbGpPWpGaD
Adapalene—RARB—Generic Transcription Pathway—ZNF77—bone cancer	0.00756	0.0109	CbGpPWpGaD
Adapalene—RXRA—Nuclear Receptor transcription pathway—NR1I2—bone cancer	0.00741	0.0106	CbGpPWpGaD
Adapalene—RARA—Generic Transcription Pathway—ZNF77—bone cancer	0.00725	0.0104	CbGpPWpGaD
Adapalene—RXRB—Generic Transcription Pathway—ZNF77—bone cancer	0.00725	0.0104	CbGpPWpGaD
Adapalene—RXRA—The citric acid (TCA) cycle and respiratory electron transport—NDUFA12—bone cancer	0.0065	0.00934	CbGpPWpGaD
Adapalene—RXRA—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	0.00628	0.00902	CbGpPWpGaD
Adapalene—RXRG—a6b1 and a6b4 Integrin signaling—MET—bone cancer	0.00605	0.00869	CbGpPWpGaD
Adapalene—Pain—Carboplatin—bone cancer	0.00578	0.0191	CcSEcCtD
Adapalene—RXRB—a6b1 and a6b4 Integrin signaling—MET—bone cancer	0.00569	0.00817	CbGpPWpGaD
Adapalene—Skin exfoliation—Cisplatin—bone cancer	0.00531	0.0175	CcSEcCtD
Adapalene—RXRA—Orphan transporters—TUBB4B—bone cancer	0.00514	0.00738	CbGpPWpGaD
Adapalene—Vesiculobullous rash—Epirubicin—bone cancer	0.00509	0.0168	CcSEcCtD
Adapalene—Vesiculobullous rash—Doxorubicin—bone cancer	0.00471	0.0155	CcSEcCtD
Adapalene—Optic neuritis—Epirubicin—bone cancer	0.00464	0.0153	CcSEcCtD
Adapalene—RXRA—PPAR Alpha Pathway—CDK4—bone cancer	0.0046	0.0066	CbGpPWpGaD
Adapalene—RXRA—Orphan transporters—TUBB2A—bone cancer	0.00444	0.00637	CbGpPWpGaD
Adapalene—Keratitis—Epirubicin—bone cancer	0.0044	0.0145	CcSEcCtD
Adapalene—Burning sensation—Methotrexate—bone cancer	0.00439	0.0145	CcSEcCtD
Adapalene—Optic neuritis—Doxorubicin—bone cancer	0.0043	0.0142	CcSEcCtD
Adapalene—RARB—Integrated Pancreatic Cancer Pathway—WT1—bone cancer	0.00427	0.00613	CbGpPWpGaD
Adapalene—Redness—Epirubicin—bone cancer	0.00423	0.0139	CcSEcCtD
Adapalene—Seborrhoeic dermatitis—Epirubicin—bone cancer	0.00419	0.0138	CcSEcCtD
Adapalene—Burning sensation—Epirubicin—bone cancer	0.00411	0.0135	CcSEcCtD
Adapalene—RARA—Integrated Pancreatic Cancer Pathway—WT1—bone cancer	0.00409	0.00588	CbGpPWpGaD
Adapalene—Keratitis—Doxorubicin—bone cancer	0.00407	0.0134	CcSEcCtD
Adapalene—RARG—Gene Expression—ZNF77—bone cancer	0.00406	0.00583	CbGpPWpGaD
Adapalene—RXRG—Regulation of Androgen receptor activity—MDM2—bone cancer	0.00394	0.00565	CbGpPWpGaD
Adapalene—Redness—Doxorubicin—bone cancer	0.00391	0.0129	CcSEcCtD
Adapalene—Face oedema—Cisplatin—bone cancer	0.0039	0.0128	CcSEcCtD
Adapalene—Seborrhoeic dermatitis—Doxorubicin—bone cancer	0.00388	0.0128	CcSEcCtD
Adapalene—Dermatitis atopic—Epirubicin—bone cancer	0.00386	0.0127	CcSEcCtD
Adapalene—Burning sensation—Doxorubicin—bone cancer	0.0038	0.0125	CcSEcCtD
Adapalene—RXRA—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.0038	0.00546	CbGpPWpGaD
Adapalene—RXRA—Generic Transcription Pathway—ZNF77—bone cancer	0.00378	0.00543	CbGpPWpGaD
Adapalene—RXRG—Gene Expression—ZNF77—bone cancer	0.00371	0.00533	CbGpPWpGaD
Adapalene—RXRB—Regulation of Androgen receptor activity—MDM2—bone cancer	0.0037	0.00531	CbGpPWpGaD
Adapalene—RARB—Gene Expression—ZNF77—bone cancer	0.00364	0.00523	CbGpPWpGaD
Adapalene—Feeling hot—Epirubicin—bone cancer	0.00364	0.012	CcSEcCtD
Adapalene—RARB—Integrated Pancreatic Cancer Pathway—SMO—bone cancer	0.00363	0.00521	CbGpPWpGaD
Adapalene—Rash pustular—Epirubicin—bone cancer	0.00358	0.0118	CcSEcCtD
Adapalene—Dermatitis atopic—Doxorubicin—bone cancer	0.00357	0.0118	CcSEcCtD
Adapalene—Stinging—Epirubicin—bone cancer	0.00352	0.0116	CcSEcCtD
Adapalene—RXRB—Gene Expression—ZNF77—bone cancer	0.00349	0.00501	CbGpPWpGaD
Adapalene—RARA—Gene Expression—ZNF77—bone cancer	0.00349	0.00501	CbGpPWpGaD
Adapalene—RARA—Integrated Pancreatic Cancer Pathway—SMO—bone cancer	0.00348	0.005	CbGpPWpGaD
Adapalene—RXRG—Regulation of Androgen receptor activity—JUN—bone cancer	0.00342	0.00491	CbGpPWpGaD
Adapalene—Skin discolouration—Methotrexate—bone cancer	0.00338	0.0111	CcSEcCtD
Adapalene—Feeling hot—Doxorubicin—bone cancer	0.00337	0.0111	CcSEcCtD
Adapalene—Rash pustular—Doxorubicin—bone cancer	0.00331	0.0109	CcSEcCtD
Adapalene—Herpes simplex—Methotrexate—bone cancer	0.00331	0.0109	CcSEcCtD
Adapalene—RARB—Integrated Pancreatic Cancer Pathway—EZH2—bone cancer	0.00331	0.00475	CbGpPWpGaD
Adapalene—Stinging—Doxorubicin—bone cancer	0.00326	0.0107	CcSEcCtD
Adapalene—RXRB—Regulation of Androgen receptor activity—JUN—bone cancer	0.00322	0.00462	CbGpPWpGaD
Adapalene—RARA—Integrated Pancreatic Cancer Pathway—EZH2—bone cancer	0.00317	0.00455	CbGpPWpGaD
Adapalene—Skin discolouration—Epirubicin—bone cancer	0.00316	0.0104	CcSEcCtD
Adapalene—Herpes simplex—Epirubicin—bone cancer	0.0031	0.0102	CcSEcCtD
Adapalene—RXRA—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.00308	0.00442	CbGpPWpGaD
Adapalene—RXRG—a6b1 and a6b4 Integrin signaling—EGFR—bone cancer	0.00307	0.0044	CbGpPWpGaD
Adapalene—Conjunctivitis—Cisplatin—bone cancer	0.00302	0.00996	CcSEcCtD
Adapalene—RARB—Integrated Pancreatic Cancer Pathway—IL3—bone cancer	0.00301	0.00432	CbGpPWpGaD
Adapalene—RARB—Integrated Pancreatic Cancer Pathway—CHEK2—bone cancer	0.00297	0.00426	CbGpPWpGaD
Adapalene—RXRA—a6b1 and a6b4 Integrin signaling—MET—bone cancer	0.00297	0.00426	CbGpPWpGaD
Adapalene—Skin discolouration—Doxorubicin—bone cancer	0.00293	0.00964	CcSEcCtD
Adapalene—Skin exfoliation—Methotrexate—bone cancer	0.00291	0.0096	CcSEcCtD
Adapalene—RARA—Integrated Pancreatic Cancer Pathway—IL3—bone cancer	0.00289	0.00415	CbGpPWpGaD
Adapalene—RXRB—a6b1 and a6b4 Integrin signaling—EGFR—bone cancer	0.00288	0.00414	CbGpPWpGaD
Adapalene—Herpes simplex—Doxorubicin—bone cancer	0.00287	0.00945	CcSEcCtD
Adapalene—RARG—Generic Transcription Pathway—NR1I2—bone cancer	0.00285	0.0041	CbGpPWpGaD
Adapalene—RARA—Integrated Pancreatic Cancer Pathway—CHEK2—bone cancer	0.00285	0.00409	CbGpPWpGaD
Adapalene—Dermatitis contact—Epirubicin—bone cancer	0.00282	0.0093	CcSEcCtD
Adapalene—Skin exfoliation—Epirubicin—bone cancer	0.00273	0.00898	CcSEcCtD
Adapalene—Dermatitis contact—Doxorubicin—bone cancer	0.00261	0.0086	CcSEcCtD
Adapalene—RXRG—Generic Transcription Pathway—NR1I2—bone cancer	0.00261	0.00375	CbGpPWpGaD
Adapalene—RARB—Generic Transcription Pathway—NR1I2—bone cancer	0.00256	0.00368	CbGpPWpGaD
Adapalene—Skin exfoliation—Doxorubicin—bone cancer	0.00252	0.00831	CcSEcCtD
Adapalene—RARB—Integrated Pancreatic Cancer Pathway—BRCA2—bone cancer	0.00252	0.00361	CbGpPWpGaD
Adapalene—RXRB—Generic Transcription Pathway—NR1I2—bone cancer	0.00245	0.00352	CbGpPWpGaD
Adapalene—RARA—Generic Transcription Pathway—NR1I2—bone cancer	0.00245	0.00352	CbGpPWpGaD
Adapalene—Erythema—Cisplatin—bone cancer	0.00243	0.00801	CcSEcCtD
Adapalene—RARA—Integrated Pancreatic Cancer Pathway—BRCA2—bone cancer	0.00241	0.00347	CbGpPWpGaD
Adapalene—Dermatitis exfoliative—Methotrexate—bone cancer	0.00235	0.00774	CcSEcCtD
Adapalene—Eczema—Epirubicin—bone cancer	0.00231	0.0076	CcSEcCtD
Adapalene—Eye pain—Epirubicin—bone cancer	0.0023	0.00757	CcSEcCtD
Adapalene—RXRG—Adipogenesis—RB1—bone cancer	0.00225	0.00323	CbGpPWpGaD
Adapalene—Dermatitis exfoliative—Epirubicin—bone cancer	0.0022	0.00724	CcSEcCtD
Adapalene—Dermatitis bullous—Epirubicin—bone cancer	0.00217	0.00715	CcSEcCtD
Adapalene—Eczema—Doxorubicin—bone cancer	0.00213	0.00703	CcSEcCtD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—WT1—bone cancer	0.00213	0.00306	CbGpPWpGaD
Adapalene—Eye pain—Doxorubicin—bone cancer	0.00212	0.007	CcSEcCtD
Adapalene—RARA—Adipogenesis—RB1—bone cancer	0.00212	0.00304	CbGpPWpGaD
Adapalene—Convulsion—Cisplatin—bone cancer	0.00211	0.00694	CcSEcCtD
Adapalene—Dermatitis exfoliative—Doxorubicin—bone cancer	0.00203	0.0067	CcSEcCtD
Adapalene—Dermatitis bullous—Doxorubicin—bone cancer	0.00201	0.00661	CcSEcCtD
Adapalene—Face oedema—Epirubicin—bone cancer	0.002	0.00659	CcSEcCtD
Adapalene—RARG—Gene Expression—FUS—bone cancer	0.00198	0.00285	CbGpPWpGaD
Adapalene—RXRA—Transcriptional regulation of white adipocyte differentiation—CDK4—bone cancer	0.00193	0.00277	CbGpPWpGaD
Adapalene—RXRA—Regulation of Androgen receptor activity—MDM2—bone cancer	0.00193	0.00277	CbGpPWpGaD
Adapalene—Dry skin—Epirubicin—bone cancer	0.0019	0.00626	CcSEcCtD
Adapalene—RARB—Integrated Pancreatic Cancer Pathway—CDK4—bone cancer	0.00187	0.00268	CbGpPWpGaD
Adapalene—Face oedema—Doxorubicin—bone cancer	0.00185	0.0061	CcSEcCtD
Adapalene—RXRA—Gene Expression—ZNF77—bone cancer	0.00182	0.00261	CbGpPWpGaD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—SMO—bone cancer	0.00181	0.00261	CbGpPWpGaD
Adapalene—RXRG—Gene Expression—FUS—bone cancer	0.00181	0.0026	CbGpPWpGaD
Adapalene—RARA—Integrated Pancreatic Cancer Pathway—CDK4—bone cancer	0.00179	0.00257	CbGpPWpGaD
Adapalene—RARB—Gene Expression—FUS—bone cancer	0.00178	0.00255	CbGpPWpGaD
Adapalene—Dry skin—Doxorubicin—bone cancer	0.00176	0.00579	CcSEcCtD
Adapalene—Photosensitivity reaction—Methotrexate—bone cancer	0.00175	0.00576	CcSEcCtD
Adapalene—RARA—Gene Expression—FUS—bone cancer	0.00171	0.00245	CbGpPWpGaD
Adapalene—RXRB—Gene Expression—FUS—bone cancer	0.00171	0.00245	CbGpPWpGaD
Adapalene—Pain—Cisplatin—bone cancer	0.0017	0.00559	CcSEcCtD
Adapalene—RXRA—Regulation of Androgen receptor activity—JUN—bone cancer	0.00168	0.00241	CbGpPWpGaD
Adapalene—Conjunctivitis—Methotrexate—bone cancer	0.00166	0.00547	CcSEcCtD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—EZH2—bone cancer	0.00165	0.00237	CbGpPWpGaD
Adapalene—RXRA—Biological oxidations—CYP3A4—bone cancer	0.00164	0.00235	CbGpPWpGaD
Adapalene—Photosensitivity reaction—Epirubicin—bone cancer	0.00164	0.00539	CcSEcCtD
Adapalene—RXRA—NRF2 pathway—GSTP1—bone cancer	0.0016	0.00229	CbGpPWpGaD
Adapalene—RXRA—NRF2 pathway—TGFBR2—bone cancer	0.0016	0.00229	CbGpPWpGaD
Adapalene—Conjunctivitis—Epirubicin—bone cancer	0.00155	0.00512	CcSEcCtD
Adapalene—Hepatitis—Methotrexate—bone cancer	0.00153	0.00505	CcSEcCtD
Adapalene—Photosensitivity reaction—Doxorubicin—bone cancer	0.00151	0.00499	CcSEcCtD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—IL3—bone cancer	0.0015	0.00216	CbGpPWpGaD
Adapalene—RXRA—a6b1 and a6b4 Integrin signaling—EGFR—bone cancer	0.0015	0.00216	CbGpPWpGaD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—CHEK2—bone cancer	0.00148	0.00213	CbGpPWpGaD
Adapalene—Hypersensitivity—Cisplatin—bone cancer	0.00146	0.00482	CcSEcCtD
Adapalene—Conjunctivitis—Doxorubicin—bone cancer	0.00144	0.00473	CcSEcCtD
Adapalene—Hepatitis—Epirubicin—bone cancer	0.00143	0.00473	CcSEcCtD
Adapalene—RXRA—Biological oxidations—GSTP1—bone cancer	0.0014	0.00201	CbGpPWpGaD
Adapalene—RARB—Integrated Pancreatic Cancer Pathway—MDM2—bone cancer	0.00138	0.00199	CbGpPWpGaD
Adapalene—RARG—Gene Expression—NR1I2—bone cancer	0.00137	0.00197	CbGpPWpGaD
Adapalene—RARB—Integrated Pancreatic Cancer Pathway—PTGS2—bone cancer	0.00133	0.00192	CbGpPWpGaD
Adapalene—Erythema—Methotrexate—bone cancer	0.00133	0.0044	CcSEcCtD
Adapalene—RARA—Integrated Pancreatic Cancer Pathway—MDM2—bone cancer	0.00133	0.00191	CbGpPWpGaD
Adapalene—Hepatitis—Doxorubicin—bone cancer	0.00133	0.00437	CcSEcCtD
Adapalene—RXRA—Generic Transcription Pathway—NR1I2—bone cancer	0.00128	0.00184	CbGpPWpGaD
Adapalene—RARA—Integrated Pancreatic Cancer Pathway—PTGS2—bone cancer	0.00128	0.00184	CbGpPWpGaD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—BRCA2—bone cancer	0.00126	0.00181	CbGpPWpGaD
Adapalene—RXRG—Gene Expression—NR1I2—bone cancer	0.00126	0.0018	CbGpPWpGaD
Adapalene—RXRA—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.00125	0.0018	CbGpPWpGaD
Adapalene—Rash—Cisplatin—bone cancer	0.00125	0.00412	CcSEcCtD
Adapalene—Dermatitis—Cisplatin—bone cancer	0.00125	0.00412	CcSEcCtD
Adapalene—Erythema—Epirubicin—bone cancer	0.00125	0.00411	CcSEcCtD
Adapalene—RARB—Gene Expression—NR1I2—bone cancer	0.00123	0.00177	CbGpPWpGaD
Adapalene—RARB—Integrated Pancreatic Cancer Pathway—JUN—bone cancer	0.0012	0.00173	CbGpPWpGaD
Adapalene—RXRB—Gene Expression—NR1I2—bone cancer	0.00118	0.0017	CbGpPWpGaD
Adapalene—RARA—Gene Expression—NR1I2—bone cancer	0.00118	0.0017	CbGpPWpGaD
Adapalene—Convulsion—Methotrexate—bone cancer	0.00116	0.00381	CcSEcCtD
Adapalene—Erythema—Doxorubicin—bone cancer	0.00116	0.00381	CcSEcCtD
Adapalene—RARA—Integrated Pancreatic Cancer Pathway—JUN—bone cancer	0.00115	0.00166	CbGpPWpGaD
Adapalene—RXRA—Adipogenesis—RB1—bone cancer	0.0011	0.00158	CbGpPWpGaD
Adapalene—RXRA—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.00108	0.00155	CbGpPWpGaD
Adapalene—Convulsion—Epirubicin—bone cancer	0.00108	0.00356	CcSEcCtD
Adapalene—RARG—Gene Expression—EIF2S1—bone cancer	0.00102	0.00146	CbGpPWpGaD
Adapalene—Convulsion—Doxorubicin—bone cancer	0.001	0.0033	CcSEcCtD
Adapalene—RXRA—Metabolism—NDUFA12—bone cancer	0.000981	0.00141	CbGpPWpGaD
Adapalene—RARB—Integrated Pancreatic Cancer Pathway—EGFR—bone cancer	0.000946	0.00136	CbGpPWpGaD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—CDK4—bone cancer	0.000933	0.00134	CbGpPWpGaD
Adapalene—Pain—Methotrexate—bone cancer	0.000931	0.00307	CcSEcCtD
Adapalene—RXRG—Gene Expression—EIF2S1—bone cancer	0.000928	0.00133	CbGpPWpGaD
Adapalene—RARB—Gene Expression—EIF2S1—bone cancer	0.00091	0.00131	CbGpPWpGaD
Adapalene—RARA—Integrated Pancreatic Cancer Pathway—EGFR—bone cancer	0.000907	0.0013	CbGpPWpGaD
Adapalene—RXRA—Gene Expression—FUS—bone cancer	0.000889	0.00128	CbGpPWpGaD
Adapalene—RARG—Gene Expression—EZH2—bone cancer	0.000882	0.00127	CbGpPWpGaD
Adapalene—RARA—Gene Expression—EIF2S1—bone cancer	0.000873	0.00125	CbGpPWpGaD
Adapalene—RXRB—Gene Expression—EIF2S1—bone cancer	0.000873	0.00125	CbGpPWpGaD
Adapalene—Pain—Epirubicin—bone cancer	0.000871	0.00287	CcSEcCtD
Adapalene—Urticaria—Methotrexate—bone cancer	0.000865	0.00285	CcSEcCtD
Adapalene—RXRA—Metabolism—NT5C3A—bone cancer	0.000813	0.00117	CbGpPWpGaD
Adapalene—Urticaria—Epirubicin—bone cancer	0.000809	0.00267	CcSEcCtD
Adapalene—RXRG—Gene Expression—EZH2—bone cancer	0.000806	0.00116	CbGpPWpGaD
Adapalene—Pain—Doxorubicin—bone cancer	0.000806	0.00266	CcSEcCtD
Adapalene—Hypersensitivity—Methotrexate—bone cancer	0.000802	0.00264	CcSEcCtD
Adapalene—RARB—Integrated Pancreatic Cancer Pathway—TP53—bone cancer	0.000794	0.00114	CbGpPWpGaD
Adapalene—RARB—Gene Expression—EZH2—bone cancer	0.000791	0.00114	CbGpPWpGaD
Adapalene—Pruritus—Methotrexate—bone cancer	0.00077	0.00254	CcSEcCtD
Adapalene—RARA—Integrated Pancreatic Cancer Pathway—TP53—bone cancer	0.000761	0.00109	CbGpPWpGaD
Adapalene—RARA—Gene Expression—EZH2—bone cancer	0.000758	0.00109	CbGpPWpGaD
Adapalene—RXRB—Gene Expression—EZH2—bone cancer	0.000758	0.00109	CbGpPWpGaD
Adapalene—Hypersensitivity—Epirubicin—bone cancer	0.000751	0.00247	CcSEcCtD
Adapalene—Urticaria—Doxorubicin—bone cancer	0.000749	0.00247	CcSEcCtD
Adapalene—Pruritus—Epirubicin—bone cancer	0.000721	0.00238	CcSEcCtD
Adapalene—Hypersensitivity—Doxorubicin—bone cancer	0.000695	0.00229	CcSEcCtD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—MDM2—bone cancer	0.000692	0.000993	CbGpPWpGaD
Adapalene—Rash—Methotrexate—bone cancer	0.000686	0.00226	CcSEcCtD
Adapalene—Dermatitis—Methotrexate—bone cancer	0.000686	0.00226	CcSEcCtD
Adapalene—Pruritus—Doxorubicin—bone cancer	0.000667	0.0022	CcSEcCtD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—PTGS2—bone cancer	0.000667	0.000957	CbGpPWpGaD
Adapalene—Rash—Epirubicin—bone cancer	0.000642	0.00212	CcSEcCtD
Adapalene—Dermatitis—Epirubicin—bone cancer	0.000642	0.00211	CcSEcCtD
Adapalene—RXRA—Gene Expression—NR1I2—bone cancer	0.000616	0.000884	CbGpPWpGaD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—JUN—bone cancer	0.000601	0.000863	CbGpPWpGaD
Adapalene—Rash—Doxorubicin—bone cancer	0.000594	0.00196	CcSEcCtD
Adapalene—Dermatitis—Doxorubicin—bone cancer	0.000594	0.00196	CcSEcCtD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—EGFR—bone cancer	0.000473	0.000679	CbGpPWpGaD
Adapalene—RXRA—Gene Expression—EIF2S1—bone cancer	0.000455	0.000653	CbGpPWpGaD
Adapalene—RXRA—Developmental Biology—MET—bone cancer	0.000436	0.000626	CbGpPWpGaD
Adapalene—RXRA—Developmental Biology—CDK4—bone cancer	0.000436	0.000626	CbGpPWpGaD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—TP53—bone cancer	0.000397	0.00057	CbGpPWpGaD
Adapalene—RXRA—Gene Expression—EZH2—bone cancer	0.000395	0.000567	CbGpPWpGaD
Adapalene—RXRA—Developmental Biology—MMP2—bone cancer	0.000364	0.000522	CbGpPWpGaD
Adapalene—RXRA—Metabolism—ENO2—bone cancer	0.000356	0.000511	CbGpPWpGaD
Adapalene—RXRA—Metabolism—DHFR—bone cancer	0.00033	0.000474	CbGpPWpGaD
Adapalene—RXRA—Metabolism—GNA11—bone cancer	0.000309	0.000443	CbGpPWpGaD
Adapalene—RXRA—Metabolism—CYP3A4—bone cancer	0.00028	0.000402	CbGpPWpGaD
Adapalene—RXRA—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	0.000278	0.0004	CbGpPWpGaD
Adapalene—RXRA—Developmental Biology—MMP9—bone cancer	0.000273	0.000393	CbGpPWpGaD
Adapalene—RXRA—Metabolism—GSTP1—bone cancer	0.000239	0.000344	CbGpPWpGaD
Adapalene—RXRA—Developmental Biology—EGFR—bone cancer	0.000221	0.000317	CbGpPWpGaD
Adapalene—RXRA—Metabolism—PTGS2—bone cancer	0.000124	0.000178	CbGpPWpGaD
